Latest Industry Articles

Abionic Receives IVDR Certification for Its Predictive Ultra-Rapid Sepsis Test

Abionic Receives IVDR Certification for Its Predictive Ultra-Rapid Sepsis Test

BSI certification agency has granted Abionic’s abioSCOPE® device and PSP test the IVDR certification for in-vitro diagnostics. This certification complies with Europe’s new In-vitro Diagnostic Regulation (IVDR), and will be required for products sold within the EU from May 2022 onward. A transiti

Read more
Abionic Webinar - Advancing the Diagnosis of Sepsis in the Intensive Care Units

Abionic Webinar - Advancing the Diagnosis of Sepsis in the Intensive Care Units

Real world evidence on the practical implementation of the Pancreatic Stone Protein (PSP) Sepsis Test   On the 22nd of September, attendees tuned in to a lively discussion on sepsis chaired by Professor Pedro Póvoa, who is currently coordinator of the Intensive Care Unit (ICU) in one of the

Read more
Pancreatic Stone Protein found to be an Early Marker for Risk Stratification in Acute Pancreatitis

Pancreatic Stone Protein found to be an Early Marker for Risk Stratification in Acute Pancreatitis

Context Growing numbers of obesity, alcohol abuse and gallstones are leading to an increase in the incidence of acute pancreatitis. This sudden inflammatory disease of the pancreas usually requires hospitalization due to high mortality and morbidity rates. In some cases, acute pancreatitis can pro

Read more
New Data Confirms the Clinical Benefit of PSP for the Diagnosis of Severe Infections

New Data Confirms the Clinical Benefit of PSP for the Diagnosis of Severe Infections

Critical Care, the top-ranked open access journal in the field of critical care medicine, published the results of a study led by Lausanne University Hospital’s Dr Philippe Eggimann and Bern University Hospital’s Dr Yok-Ai Que this month [1]. The authors analyzed pooled data from five cohorts showi

Read more
The PSP Biomarker Rises Earlier than CRP and PCT in Sepsis, a New Study Shows

The PSP Biomarker Rises Earlier than CRP and PCT in Sepsis, a New Study Shows

Sepsis is a global healthcare problem, with 50 million cases each year and 11 million related deaths  1 . It’s the life-threatening complication of an infection, in which the host’s immune response to a pathogen damages its own organs. The clinical diagnosis of sepsis relies mostly on signs an

Read more
Great Symposium on the PSP Sepsis Biomarker - Hosted By Abionic and Palex at the GALISEPSIS 2021

Great Symposium on the PSP Sepsis Biomarker - Hosted By Abionic and Palex at the GALISEPSIS 2021

On April 6th, Abionic and Palex joined forces to participate in the first day of GaliSepsis, the National Sepsis Course hosted and organized virtually by the Ourense University Hospital Complex (CHUO) in Spain. With the aim of updating the most important concepts and reviewing the latest developme

Read more
Ortho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available

Ortho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS ®  B•R•A•H•M•S PCT (Procalcitonin) assay, now commercially available to help clinicians identify sepsis and othe

Read more
Atrial Fibrillation and Sepsis: A Life-Threatening Combination

Atrial Fibrillation and Sepsis: A Life-Threatening Combination

Almost half of the patients with sepsis suffer from myocardial depression and a reduced ejection fraction. Sepsis can also cause changes in circulating volume, vascular tone, and coronary blood flow, all of which affect heart function and heart rate. Serum catecholamine levels and direct measuremen

Read more
Hampshire hospitals NHS foundation trust pioneers use of diagnostic tools for earlier optimisation of antibiotic therapy for sepsis patients

HHFT pioneers use of diagnostic tools for earlier optimisation for sepsis patients

… Antimicrobial Susceptibility Testing (AST) times reduced from days to hours….   Hampshire Hospitals NHS Foundation Trust (HHFT) is pioneering the use of the Accelerate Pheno TM system from Accelerate Diagnostics, Inc., (Accelerate Diagnostics) a leading in vitro diagnostics company, t

Read more
Hospital de La Princesa shortens antibiotic adaptation treatment for severe sepsis using a new diagnosis tool

Hospital de La Princesa shortens antibiotic adaptation treatment for severe sepsis

In positive blood cultures, the Accelerate Pheno TM system identifies the agent causing the infection in 90 minutes and around 5 hours afterwards it provides information on the antibiotic sensitivity of the pathogen, which is 28 hours less than the current conventional system used in the La Pri

Read more